Panoramica dell'azienda
FitLife Brands, Inc. operates within the consumer defensive sector, specifically focusing on the packaged foods industry, where it delivers nutritional supplements and wellness products to health-conscious consumers across the United States and international markets. The company's portfolio encompasses a diverse range of offerings, including specialized solutions for weight loss, sports nutrition, and general health, with a distinct strategic emphasis on natural, vegan, and organic formulations. As a relatively small-cap entity, FitLife Brands, Inc. maintains a market capitalization of $90.34 million and employs a workforce of 81 individuals to support its global distribution and operational needs. The annual revenue generated over the trailing twelve months stands at $81.46 million, indicating that the company functions as a niche player with a market capitalization that suggests limited scale relative to its sector peers, yet provides a specialized avenue for exposure to the expanding wellness economy.
Salute finanziaria
The financial performance of FitLife Brands, Inc. over the trailing twelve months reveals a revenue stream of $81.46 million, which resulted in a net income of $6.33 million and an EBITDA of $13.60 million. The disparity between the total revenue and the final net income highlights a cost structure where operating expenses, taxes, and interest charges consume approximately 22.2% of gross sales, reflecting the rigorous cost management required in the packaged foods sector. However, the company's cash position presents a significant challenge, as the free cash flow recorded is negative at -$1,449,625, signaling a potential strain on liquidity that limits immediate financial flexibility for capital expenditures or acquisitions. Despite this cash burn, the company holds $1.65 million in cash assets against a total debt load of $45.27 million, resulting in a debt-to-equity ratio of 103.75% that characterizes a highly leveraged balance sheet rather than a conservative one. Profitability efficiency is further dissected by three key margins: a gross margin of 39.9%, an operating margin of 12.1%, and a profit margin of 7.8%, where the compression between gross and operating margins indicates significant selling, general, and administrative costs. Liquidity risk is mitigated to a moderate extent by a current ratio of 1.53, suggesting that current assets exceed current liabilities by 53%, providing a buffer against short-term obligations. Furthermore, the return on equity stands at 15.9% while the return on assets is 10.0%, metrics that reveal management is effectively utilizing shareholder capital to generate returns, albeit with the leverage amplifying the equity return significantly above the asset return.
Valutazione del valore
Valuation metrics for FitLife Brands, Inc. indicate a market that expects significant earnings improvement, evidenced by a trailing P/E ratio of 15.27 compared to a forward P/E of 5.29. This substantial divergence between the historical and forward multiples implies that the market anticipates a sharp contraction in current earnings or, more likely in this context, a normalization of earnings after a period of volatility that has depressed the forward multiple. The price-to-book ratio is recorded at 2.07, suggesting that the stock trades at a 107% premium over its book value, which may reflect intangible assets or growth expectations not fully captured in historical financial statements. Alternative valuation measures provide additional context, with a price-to-sales ratio of 1.11 and an EV/EBITDA of 9.85, indicating that the company is valued roughly in line with its sales generation while maintaining an enterprise value relative to earnings that is slightly elevated compared to the historical P/E. Price volatility is contextualized by a 52-week trading range between $9.03 and $20.98, placing the current valuation roughly 56% below the 52-week high and approximately 112% above the 52-week low, highlighting a wide fluctuation band typical of small-cap biotech or wellness stocks. Additionally, the company exhibits a beta of 0.38, which signifies that its stock price is expected to be significantly less volatile than the broader market, offering a lower-risk profile in terms of systematic risk exposure despite the high leverage present on its balance sheet.
Growth & Income
Growth dynamics for FitLife Brands, Inc. are characterized by a revenue growth rate of 72.6% year-over-year, which contrasts sharply with an earnings growth rate of -23.8%. This divergence indicates that while top-line sales are expanding rapidly, earnings are contracting, likely due to the aforementioned negative free cash flow and high debt servicing costs which are eroding profitability faster than revenue can be generated. The company does not distribute dividends to shareholders, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning that all available earnings are retained within the business to fund operations, service debt, or pursue organic growth initiatives rather than being paid out as income. Consequently, the overall growth and income profile of FitLife Brands, Inc. is defined by aggressive top-line expansion coupled with significant earnings contraction and a complete reinvestment strategy that prioritizes operational scaling and debt management over immediate income distribution.